Europe — EMA

Letrozol Denk (Letrozole)

Letrozole, the active ingredient in Letrozol Denk, is an aromatase inhibitor presented as a tablet for oral use. It treats hormone‑receptor positive breast cancer in post‑menopausal women.

Letrozole

Request sourcing

Pack/s

What is Letrozole?

Letrozole, the active ingredient in Letrozol Denk, is an aromatase inhibitor presented as a tablet for oral use. It treats hormone‑receptor positive breast cancer in post‑menopausal women. GNH USA supplies Letrozol Denk as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

GNH USA supplies Letrozol Denk as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

What is Letrozole used for?

Letrozole acts by targeting the estrogen‑production pathway in hormone‑dependent cancers.

- Breast Cancer (post‑menopausal): Reduces the risk of disease recurrence and improves overall survival. - Endocrine Disruption of the menstrual cycle : Provides symptom relief for women with ovarian cysts or PCOS by lower estrogen levels. - Fertility Pres‑‑ pres    -  \

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →